Bill Li, MD, PhD

Education

• Fellowship: Breast Pathology, MD Anderson Cancer Center
• Fellowship: Oncological Pathology, MD Anderson Cancer Center
• Residency: The Houston Methodist Hospital
• Research Associate, Baylor College of Medicine
• PhD: University of Maryland, College Park
• Medical Degree: Beijing Medical University

Dr. Li is a nationally and internationally renowned breast pathologist. Dr. Li has authored >110 peer-reviewed publications as well as numerous review articles and book chapters including the upcoming 6th Edition of the WHO Classification of Tumors of the Breast (WHO blue book). Dr. Li was inducted to the Emory University MilliPub Club twice for two of his seminal first-author papers in the field of breast cancer (PMID: 18445819 and 19666588) which have been cited >1400 and >1100 times, respectively (Web of Science). Dr. Li is a principal investigator or co-principal investigator of multiple active research grants funded by NIH, foundations, industry and institutions. Dr. Li and his laboratory focus on the development of biomarkers to predict breast cancer risk, prognosis and response to therapies. Dr. Li is an Associate Editor for Breast Cancer Research and Treatment, and Section Editor for breast pathology for Archives of Pathology and Laboratory Medicine and Human Pathology Reports. He is also a member of the Editorial Boards of Human Pathology, Clinical Breast Cancer and JNCI Cancer Spectrum. Dr. Li currently serves on multiple national committees and has organized several national courses and meetings. Dr. Li has mentored numerous PhD and graduate students, residents, fellows and visiting scholars and has been frequently invited to give lectures at national/international conferences including the USCAP and CAP Annual Meetings and the Lynn Sage Breast Cancer Symposium.

View Publications